Results 1 to 10 of about 21,265 (190)

MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA. [PDF]

open access: yesPLoS ONE, 2016
Translation of mRNA in alternate reading frames (ARF) is a naturally occurring process heretofore underappreciated as a generator of protein diversity. The MUC1 gene encodes MUC1-TM, a signal-transducing trans-membrane protein highly expressed in human ...
Michael Chalick   +12 more
doaj   +4 more sources

Detection of Circulating Mammary Mucin (MUC1) and MUC1 Immune Complexes (MUC1-CIC) in Healthy Women [PDF]

open access: yesThe International Journal of Biological Markers, 2001
There is convincing epidemiological evidence that multiparity provides protection against the development of breast cancer. In the present study we evaluated the levels of MUC1 and MUC1 circulating immune complexes (MUC1-CIC) in 135 serum samples ...
M.V. Croce   +3 more
doaj   +3 more sources

Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody

open access: yesAntibodies, 2023
Mucin1 (MUC1) is abnormally glycosylated and overexpressed in a variety of epithelial cancers and plays a critical role in tumor progression. MUC1 has received remark attention as an oncogenic molecule and is considered a valuable tumor target for ...
Jun Fang, Shifa Lai, Haoyang Yu, Lan Ma
doaj   +3 more sources

MUC1-targeted CAR-T cell secreted anti-PD-1 IgG antibody enhances antitumor activity in Cholangiocarcinoma [PDF]

open access: yesScientific Reports
Cholangiocarcinoma (CCA) is a highly aggressive malignancy with poor prognosis and limited therapeutic options. Gene expression analysis of patient samples and flow cytometry of CCA cell lines demonstrated significant upregulation of MUC1 and PD-L1 ...
Nattarika Khuisangeam   +9 more
doaj   +2 more sources

A predicted two to tango interaction between MUC1 and SOX2: a unique opportunity to target cancer stem cells [PDF]

open access: yesWorld Cancer Research Journal, 2022
Objective: Cancer stem cell (CSC) genes are emerging as cancer therapeutic targets. MUC1 is a cell surface-associated glycoprotein that is aberrantly over‐expressed in >60% of human cancers including breast cancer.
A. Dutta, S. Paul
doaj   +1 more source

Local effects of regulatory T cells in MUC1 transgenic mice potentiate growth of MUC1 expressing tumor cells in vivo. [PDF]

open access: yesPLoS ONE, 2012
MUC1 transgenic (MUC1.Tg) mice have widely been used as model recipients of cancer immunotherapy with MUC1. Although MUC1.Tg mice have previously been shown to be immunologically tolerant to MUC1, the involvement of regulatory T (Treg) cells in this ...
Daisuke Sugiura   +6 more
doaj   +1 more source

Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells. [PDF]

open access: yesPLoS ONE, 2018
Muc1 is one of the most studied tumor antigens. However, antibodies or antibody-toxin conjugates against Muc1 have not shown significant efficacy for tumors with Muc1 overexpression.
Yumei Li   +8 more
doaj   +1 more source

The MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomes. [PDF]

open access: yesPLoS ONE, 2012
MUC1 is a large transmembrane glycoprotein and oncogene expressed by epithelial cells and overexpressed and underglycosylated in cancer cells. The MUC1 cytoplasmic subunit (MUC1-C) can translocate to the nucleus and regulate gene expression.
Priyadarsini Kumar   +5 more
doaj   +1 more source

Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy. [PDF]

open access: yesPLoS ONE, 2014
The MUC1 tumor associated antigen is highly expressed on a range of tumors. Its broad distribution on primary tumors and metastases renders it an attractive target for immunotherapy. After synthesis MUC1 is cleaved, yielding a large soluble extracellular
Riva Kovjazin   +4 more
doaj   +1 more source

MUC1c regulates cell survival in pancreatic cancer by preventing lysosomal permeabilization. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND:MUC1 is a type I transmembrane glycoprotein aberrantly overexpressed in various cancer cells including pancreatic cancer. The cytosolic end of MUC1 (MUC1-c) is extensively involved in a number of signaling pathways.
Sulagna Banerjee   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy